Can a Patient's own immune cells fight tough cancers?
NCT ID NCT05098197
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial is testing a treatment called tumor-infiltrating lymphocytes (TILs) in 50 people with advanced liver or pancreatic cancers that have not responded to standard treatments. Doctors take immune cells from a patient's tumor, grow them in a lab, and then infuse them back into the patient after a short course of chemotherapy. The goal is to see if this approach is safe and can shrink tumors or slow cancer growth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tumor-infiltrating lymphocytes (TILs)
- What this could lead to
- If successful, this could point toward a new treatment option for advanced liver and pancreatic cancers that have not responded to standard therapies.
- What could go wrong
- This is a very early (Phase 1) trial with only 50 participants, so results may not apply broadly. The treatment involves strong chemotherapy beforehand, which can cause serious side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOBILIARY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Tenth People's Hospital
RECRUITINGShanghai, Shanghai Municipality, 200000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Patient's own immune cells fight advanced cancer?
- Can chemo and radiation steal fertility? a massive study aims to find out
- Cancer patients face more treatment side effects from rare lung infections
- ICU delirium drug study pulled before starting
- Tiny study compares trazodone and quetiapine for ICU delirium – but was cut short
- Which surgery is better for uterine septum? new trial aims to find out